期刊文献+

1990—2019年中国人群退行性二尖瓣病变疾病负担研究 被引量:2

The disease burden of degenerative mitral valve disease in the Chinese population from 1990 to 2019
原文传递
导出
摘要 目的探讨1990至2019年中国人群退行性二尖瓣病变(DMVD)疾病负担变化趋势。方法基于2019年全球疾病负担研究(GBD 2019)数据库,采用患病人数、新发病例数、死亡人数、伤残调整寿命年(DALY)以及患病率、发病率、死亡率、DALY率及其年龄标化率等指标,分析1990至2019年中国人群DMVD疾病负担变化趋势。结果2019年中国DMVD患病人数、新发病例数及死亡人数分别为461.2、27.0、0.129万例,与1990年相比分别增长了209.0%、199.1%和13.2%。2019年DMVD的年龄标化患病率、发病率和死亡率分别为228.1/10万、12.7/10万和0.075/10万,与1990年相比,变化率分别为32.6%、42.8%和-54.1%。另外,2019年的数据还显示,女性的年龄标化患病率和发病率均高于男性[年龄标化患病率:男性190.1(181.5~198.9)/10万、女性262.0(250.3~273.9)/10万;年龄标化发病率:男性10.5(10.0~11.0)/10万、女性14.9(14.3~15.6)/10万];DMVD患病人数最多的年龄段为65~69岁,而发病率最高的年龄段为60~64岁。1990至2019年,中国因DMVD导致的DALY呈上升趋势,由1990年的4.6万人年升至2019年的6.9万人年,增长了49.4%;而年龄标化DALY率持续下降,由1990年的5.5/10万降至2019年的3.8/10万,降幅30.8%,且女性的DALY和年龄标化DALY率在不同年份均高于男性。结论1990至2019年中国DMVD的DALY及年龄标化患病率、发病率呈持续上升趋势,DMVD所致的疾病负担严峻。 Objective To explore the trend of disease burden of degenerative mitral valve disease(DMVD)in the Chinese population from 1990 to 2019.Methods Based on the 2019 Global Burden of Disease database(GBD 2019),the number of patients,the number of new cases,the number of deaths,the disability-adjusted life years(DALY)as well as the prevalence,incidence and death rate,DALY rate and their age-standardized rates were used to analyze the trend of the burden of DMVD in the Chinese population from 1990 to 2019.Results In 2019,the number of patients,the number of new cases,and the number of deaths with DMVD in China were 461.2,27.0 and 0.129 ten thousand,respectively,which increased by 209.0%,199.1%and 13.2%when compared with 1990.In 2019,the age-standardized prevalence,incidence and death rate were 228.1/100000,12.7/100000 and 0.075/100000,respectively.Compared with 1990,the change of the age-standardized prevalence,incidence and death rate were 32.6%,42.8%and-54.1%,respectively.In addition,the 2019 data also showed that the age-standardized prevalence and incidence were higher in females than in males(the age-standardized prevalence was 190.1(181.5-198.9)/100000 for males and 262.0(250.3-273.9)/100000 for females);the age-standardized incidence was 10.5(10.0-11.0)/100000 for males and 14.9(14.3-15.6)/100000 for females.The age group with the largest number of DMVD patients was 65 to 69 years old,and the highest incidence was 60 to 64 years old.From 1990 to 2019,DALY caused by DMVD showed an upward trend in China,from 46439 person-years in 1990 to 69402 person-years in 2019,with an increase of 49.4%.While the age-standardized DALY rate continued to decline,from 5.5/100000 in 1990 to 3.8/100000 in 2019,with a drop of 30.8%.The DALY and the age-standardized DALY rate of females were always higher than that of males in different years.Conclusion From 1990 to 2019,DALY and the age-standardized prevalence and incidence of DMVD in China shows an increasing trend,and the disease burden caused by DMVD is severe in China.
作者 王梦龙 魏成 徐瑶 张记收 陈静 万军 江洪 Wang Menglong;Wei Cheng;Xu Yao;Zhang Jishou;Chen Jing;Wan Jun;Jiang Hong(Department of Cardiology,Renmin Hospital of Wuhan University,Cardiovascular Research Institute,Wuhan University,Hubei Key Laboratory of Cardiology,Wuhan 430060,China)
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2022年第2期172-178,共7页 Chinese Journal of Cardiology
基金 国家自然科学基金(81970287,82070436) 国家级大学生创新创业训练计划项目(202110486083)。
关键词 疾病负担 二尖瓣狭窄 二尖瓣反流 二尖瓣关闭不全 心脏瓣膜病 Burden of diseases Mitral stenosis Mitral regurgitation Mitral insufficiency Valvular heart disease
  • 相关文献

参考文献7

二级参考文献59

  • 1中国心血管健康与疾病报告编写组,王增武,胡盛寿.中国心血管健康与疾病报告2019概要[J].中华老年病研究电子杂志,2020(4):4-15. 被引量:906
  • 2Dujardin KS,Enriquez-Sarano M,Bailey KR,et al. Effect of losartan on degree of mitral regurgitation quantified by echocardiography[J]. Am J Cardiol,2001,87(5):570-6.
  • 3Nemoto S,Hamawaki M,De Freitas G,et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta- adrenergicreceptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation[J]. J Am Coil Cardiol,2002,40(1): 149-54.
  • 4Grigioni F,Enriquez-Sarano M,Ling L,et al. Sudden death in mitral regurgitation due to flail leaflet[J]. J Am Coil Cardiol,1999,34(7):2078-85.
  • 5Enriquez-Sarano M,Avierinos JF,Messika-Zeitoun D,et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation[J]. N Engl J Med,2005,352(9):875- 83.
  • 6Enriquez-Sarano M,Akins CW,Vahanian A. Mitral regurgitation[J]. Lancet,2009,373(9672): 1382-94.
  • 7Avierinos JF,Gersh BJ,Melton LJ III,et al. Natural history of asymptomatic mitral valve prolapse in the community[J]. Circulation, 2002,106(11):1355-61.
  • 8KangDH,Kim JH,Rim JH,et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation[J]. Circulation,2009,119(6):797-804.
  • 9Avierinos JF,Inamo J,Grigioni F,et al. Sex differences in morphology and outcomes of mitral valve prolapse[J]. Ann Intern Med, 2008,149(11):787-95.
  • 10Bonow RO,Carabello BA,Kanu C,et al. ACC/AHA 2006 uidelines for the management of patients with valvular heart tisease[J]. Circulation,2006,114(5):e84-e231.

共引文献79

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部